Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).
about
A reflection on HIV/AIDS research after 25 yearsFunctional interactions of human immunodeficiency virus type 1 integrase with human and yeast HSP60Interaction of complement and specific antibodies with the external glycoprotein 120 of HIV-1Molecular and biotechnological aspects of microbial proteasesHIV-1 integrase crosslinked oligomers are active in vitroMyristoylation-dependent replication and assembly of human immunodeficiency virus 1Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replicationOctapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivityPathogenesis of human immunodeficiency virus infectionVisna virus exhibits a complex transcriptional pattern: one aspect of gene expression shared with the acquired immunodeficiency syndrome retrovirusInhibition of Hepatitis C Virus (HCV) RNA Polymerase by DNA Aptamers: Mechanism of Inhibition of In Vitro RNA Synthesis and Effect on HCV-Infected CellsHuman tRNALys3UUU Is Pre-Structured by Natural Modifications for Cognate and Wobble Codon Binding through Keto–Enol TautomerismAnti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusionHuman immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cellsHuman immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue cultureInhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitorsCharacterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation.Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1Nucleotide sequence and genomic organization of feline immunodeficiency virus.Conservation of the central proline-rich (PxxP) motifs of human immunodeficiency virus type 1 Nef protein during the disease progression in two hemophiliac patients.Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.Pandemic HIV-1 Vpu overcomes intrinsic herd immunity mediated by tetherin.The emerging role of long non-coding RNAs in HIV infection.Matrix-assisted laser desorption ionization/mass spectrometry mapping of human immunodeficiency virus-gp120 epitopes recognized by a limited polyclonal antibody.Comparison of two host cell range variants of feline immunodeficiency virus.Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genomeExpression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants.rpt-1, an intracellular protein from helper/inducer T cells that regulates gene expression of interleukin 2 receptor and human immunodeficiency virus type 1Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization.Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120Evolutionary origin of human and simian immunodeficiency viruses.Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides.Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1.Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genomeConserved cysteine and histidine residues of the avian myeloblastosis virus nucleocapsid protein are essential for viral replication but are not "zinc-binding fingers".High-level replication of human immunodeficiency virus in thymocytes requires NF-kappaB activation through interaction with thymic epithelial cells.Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding.Inhibition of lysosome and proteasome function enhances human immunodeficiency virus type 1 infection.
P2860
Q21245200-F43A4ED4-733D-4BE5-8EE7-4394B85D5F9EQ24529204-E83FB395-88A4-4951-8678-CEA8F153DE4EQ24541449-65AF37AD-91C1-483B-B019-923C0E9DB168Q24548591-4B9D88A1-4901-4C34-9FE4-AA9E8E0C65B8Q24556625-DCC899BC-794C-4D3F-8E1F-203F064F9728Q24559906-6BA377FF-6FFE-452D-A466-BAB814B41B4FQ24563503-90969837-9E24-4103-987B-CFA424C768BDQ24628269-317B430E-1BFA-40B4-AB95-A675CF6423DAQ24634681-059384B7-C3EF-4428-B86F-51705D3F3C39Q24648639-6053F874-7760-4E40-B96E-0F188FE697B2Q27486247-B266F617-D050-42DF-9D56-75207C669CA9Q27676632-989A9DB6-EB3F-4451-9CA0-FD0A736F1A9DQ28316430-CCC54322-FC09-4A40-8A9A-9B2AAAAD54FBQ28318483-1973576A-EAE6-42D0-9810-7A41F0C96C5DQ28324214-41ECA19F-9E7F-4536-BBC5-C0896EE4138DQ28355570-2872B501-E5B0-47BA-B5C5-986ECE079020Q28646771-FDA8B54A-43DB-49AA-A504-6492D1280D6AQ28646878-D74FCAC4-3F51-4960-A52D-9DBE78DB754BQ29619512-20A3FAE4-E751-460D-8AE3-A54C5F77EA56Q30011272-15F1D86E-F098-443C-A5A7-05F5E9F796A4Q30175327-533554C7-2725-43F3-9F04-8F44585B8CF3Q30356755-587E2E25-A305-4D0F-B60C-21C879E71717Q30376824-67657FE1-25CC-43A4-9104-CEF30AF3D1FFQ30377278-1BD28A7D-BAE0-431A-B407-7B7817072254Q32049913-0B53A404-B2A4-47FB-835F-F20EB02E1A02Q33257781-14A826BD-5495-4D12-9053-8371FC2CDF34Q33407962-B89CD97D-E4D2-41FF-B186-86788CA70F77Q33554232-D7E32E41-B994-4EB2-A8E6-C42014D3225AQ33567423-3A22F59A-D361-4C8A-843F-5493CF0C3A9FQ33567984-0649EE73-C573-41C3-A804-61D8C13F051FQ33571605-0264B86B-23EC-4821-B637-C0F9DCB8C3BCQ33604826-1E5779A7-6232-45C9-A404-95D869FE6C20Q33632668-3E387FED-6E0C-42FB-A23B-6C67C6F0AB77Q33635256-C51A487D-73A1-4066-9CDC-8800DC4F44A7Q33639547-1C06030E-1D3A-42B7-9FA0-1D93C05BF5F3Q33649232-C3C25D0D-8CAD-4E4E-B26C-8CE99FEDB307Q33650421-67B54201-1E8F-4061-815C-263E1CEAD42AQ33653163-8618A5CF-954B-4B8B-9768-3562460BCFF6Q33684251-FFB7CB01-0B16-441A-B5E2-C18C2CC3BEF1Q33754991-4A066F7E-B68B-42DA-B803-2D3CA87AC1E5
P2860
Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).
@en
Nucleotide sequence and expression of an AIDS-associated retrovirus
@nl
type
label
Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).
@en
Nucleotide sequence and expression of an AIDS-associated retrovirus
@nl
prefLabel
Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).
@en
Nucleotide sequence and expression of an AIDS-associated retrovirus
@nl
P2093
P356
P1433
P1476
Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).
@en
P2093
Brown-Shimer SL
Randolph A
Sanchez-Pescador R
Steimer KS
Stempien MM
P304
P356
10.1126/SCIENCE.2578227
P407
P577
1985-02-01T00:00:00Z